Novoprotein Scientific

Novoprotein Scientific EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Novoprotein Scientific (688137.SS) as of Oct 25, 2026 is -66.69 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -37.49 M CNY — a change of 77.88% (lower).

EBITDA

-66.69 MCNY

YoY

77.88%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Novoprotein Scientific is 2025 -66.69 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Novoprotein Scientific was 2024 -37.49 M CNY. It decreases by 77.88% lower compared to the previous year.

The Novoprotein Scientific EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-7.80 M CNY
Jan 1, 2020
96.23 M CNY
Jan 1, 2021
198.96 M CNY
Jan 1, 2022
122.25 M CNY
Jan 1, 2023
3.95 M CNY
Jan 1, 2024
-37.49 M CNY
Jan 1, 2025
-66.69 M CNY
The Novoprotein Scientific EBITDA history
YEAREBITDAYoY
-66.69 MCNY+77.88%
-37.49 MCNY-1,050.26%
3.95 MCNY-96.77%
122.25 MCNY-38.55%
198.96 MCNY+106.75%
96.23 MCNY-1,333.73%
-7.80 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Novoprotein Scientific Stock analysis

What does Novoprotein Scientific do? Novoprotein Scientific Inc generates revenue through the development, production, and sale of recombinant protein solutions. The company offers target and factor proteins, recombinant antibodies, enzymes, and reagents, along with technical services. Its main products include novel coronavirus diagnostic antibodies, antigens, pseudoviruses, non-structural proteins, and mRNA raw material enzymes and reagents. These products are primarily sold to customers in biological medicine, life science research, in vitro diagnostics, and mRNA vaccine drug sectors. The firm serves both domestic and international markets with its comprehensive portfolio of protein-based solutions. The company's revenue streams are derived from the sale of specialized biological reagents and technical services. Customers in the pharmaceutical and biotechnology industries purchase these products for research and diagnostic applications. The firm's focus on novel coronavirus-related products positions it within the healthcare and vaccine development markets. Novoprotein Scientific Inc targets both domestic Chinese and overseas markets for its protein application solutions. Novoprotein Scientific Inc's business model centers on providing high-value recombinant protein products and services for the life science and healthcare sectors. The company's product portfolio includes diagnostic tools for viral detection and mRNA vaccine components. These offerings are tailored to meet the needs of research institutions, diagnostic laboratories, and pharmaceutical companies. The firm's technical services support customers in developing and implementing protein-based solutions across multiple applications. Novoprotein Scientific is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novoprotein Scientific stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Novoprotein Scientific is -66.69 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Novoprotein Scientific changed from -37.49 M CNY to -66.69 M CNY, representing a 77.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Novoprotein Scientific since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Novoprotein Scientific historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Novoprotein Scientific

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Novoprotein Scientific